Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14600 | 693 | 35.0 | 68% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
540 | 13989 | FLUOROQUINOLONES//CIPROFLOXACIN//QUINOLONES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PRULIFLOXACIN | Author keyword | 20 | 53% | 4% | 27 |
2 | ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS | Author keyword | 16 | 53% | 3% | 21 |
3 | ACUTE EXACERBATION OF CHRONIC BRONCHITIS | Author keyword | 9 | 48% | 2% | 14 |
4 | ULIFLOXACIN | Author keyword | 8 | 60% | 1% | 9 |
5 | NM394 | Author keyword | 6 | 80% | 1% | 4 |
6 | ACUTE BACTERIAL EXACERBATION OF CHRONIC BRONCHITIS | Author keyword | 6 | 100% | 1% | 4 |
7 | CAS 112984 60 8 | Author keyword | 6 | 100% | 1% | 4 |
8 | CAS 123447 62 1 | Author keyword | 6 | 100% | 1% | 4 |
9 | EXACERBATION OF CHRONIC BRONCHITIS | Author keyword | 4 | 67% | 1% | 4 |
10 | ACUTE BACTERIAL EXACERBATION | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ACUTE BACTERIAL EXACERBATIONS | 60 | 59% | 10% | 67 |
2 | NM441 | 36 | 83% | 3% | 20 |
3 | BRONCHIAL MICROBIAL PATTERNS | 17 | 70% | 2% | 14 |
4 | AF 3013 | 17 | 100% | 1% | 8 |
5 | MOXIFLOXACIN THERAPY | 15 | 71% | 2% | 12 |
6 | NM394 | 12 | 86% | 1% | 6 |
7 | PROTECTED SPECIMEN BRUSH | 10 | 14% | 10% | 71 |
8 | INFECTIVE EXACERBATIONS | 10 | 63% | 1% | 10 |
9 | COURSE 5 DAY MOXIFLOXACIN | 7 | 57% | 1% | 8 |
10 | MICROBIAL PATTERNS | 6 | 80% | 1% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Role of infection in exacerbations of chronic obstructive pulmonary disease | 2015 | 2 | 52 | 73% |
Current Concepts: Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease | 2008 | 273 | 61 | 30% |
Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review | 2007 | 28 | 18 | 56% |
ANTIBIOTICS IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE EXACERBATIONS - A METAANALYSIS | 1995 | 352 | 17 | 47% |
Chronic bronchial infection in COPD. Is there an infective phenotype? | 2013 | 10 | 101 | 43% |
Lung microbiology and exacerbations in COPD | 2012 | 15 | 133 | 37% |
Antibiotics for exacerbations of chronic obstructive pulmonary disease | 2012 | 2 | 10 | 90% |
Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis and COPD: a systematic review and meta-analysis | 2014 | 3 | 31 | 55% |
Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease | 2013 | 8 | 104 | 41% |
Prulifloxacin: a review focusing on its use beyond respiratory and urinary tract infections | 2011 | 5 | 39 | 44% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FDZ IRCCS | 2 | 67% | 0.3% | 2 |
2 | CLIN TORAX IDIB S | 1 | 31% | 0.6% | 4 |
3 | WESTERN NEW YORK HEALTHCARE SYST | 1 | 38% | 0.4% | 3 |
4 | PULM 111C | 1 | 100% | 0.3% | 2 |
5 | P INFLAMMAT THER Y AREA | 1 | 40% | 0.3% | 2 |
6 | UNIT ORTHO MCNEIL INC | 1 | 40% | 0.3% | 2 |
7 | VET AFFAIRS OUTPATIENT CLIN | 1 | 33% | 0.3% | 2 |
8 | ACRAF SPA | 1 | 50% | 0.1% | 1 |
9 | BOLNISN GOLN | 1 | 50% | 0.1% | 1 |
10 | CARDIAC CRIT CARE SERV | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000216297 | COPD//CHRONIC OBSTRUCTIVE PULMONARY DISEASE//INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 | 0.0000161165 | SAHMRI INFECT IMMUN THEME//CYST FIBROSIS UNIT//OROPHARYNGEAL FLORA |
3 | 0.0000152844 | GEMIFLOXACIN//GEMIFLOXACIN MESYLATE//GARENOXACIN |
4 | 0.0000115679 | AZITHROMYCIN//CLARITHROMYCIN//DIRITHROMYCIN |
5 | 0.0000113856 | CEFTIBUTEN//CEFDINIR//CEFETAMET PIVOXIL |
6 | 0.0000103542 | BRONCHIECTASIS//MIDDLE LOBE SYNDROME//GUANGZHOU P DISAFFILIATED HOSP 1 |
7 | 0.0000094777 | RUFLOXACIN//ONCE A DAY ADMINISTRATION//RUFLOXACIN HYDROCHLORIDE |
8 | 0.0000092762 | COMMUNITY ACQUIRED PNEUMONIA//PNEUMONIA SEVERITY INDEX//CURB 65 |
9 | 0.0000092275 | MORAXELLA CATARRHALIS//BRANHAMELLA CATARRHALIS//VACCINE SECT |
10 | 0.0000089917 | HAEMOPHILUS INFLUENZAE//NONTYPEABLE HAEMOPHILUS INFLUENZAE//NTHI |